(R)-5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one

Catalog No. :
ACPAZM875
CAS No. :
17654-19-2
Molecular Formula :
C15H12O5
Molecular Weight :
272.26

IUPAC Name:(R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one

(R)-5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$86.00Login to see priceIn stockInquiry
100mg98%$136.00Login to see priceIn stockInquiry
250mg98%$275.00Login to see priceIn stockInquiry
1g98%$691.00Login to see priceIn stockInquiry
5g98%$2081.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
IUPAC Name(R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
MDL No.MFCD03265520
Molecular FormulaC15H12O5
Molecular Weight272.26
SMILESO=C1C[C@H](C2=CC=C(O)C=C2)OC3=C1C(O)=CC(O)=C3
InChI KeyFTVWIRXFELQLPI-CYBMUJFWSA-N
SynonymR-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-Benzopyran-4-one;(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one;(R)-Naringenin;Naringenin (R)-Isomer;4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (2R)-;(+)-Naringenin
CAS No.17654-19-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPAZM875 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPAZM875 route product structure diagram
    ACPAZM87517654-19-2 In Stock
Inquiry

2. ACPAZM875 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPAZM875 route product structure diagram
    ACPAZM87517654-19-2 In Stock
Inquiry

Comments (0)